글로벌 치주질환 치료 시장 – 2030년까지의 산업 동향 및 예측

치주질환 치료 시장 분석 및 규모

치주 질환은 경미한 것에서 심각한 것까지 다양하며 치료하지 않으면 치아를 잃을 수 있습니다. 글로벌 치주 치료제 시장 성장의 주요 요인은 구강 건강의 중요성에 대한 인식 증가, 인구 고령화, 새로운 제품 및 기술 개발입니다. 잇몸 질환에 대한 비수술적 치료 절차에는 항균 제품 사용과 구강의 심층 세척이 포함되며 이는 초기 단계에서 치주 질환을 역전시키는 데 충분한 것으로 입증되었습니다. 국소 및 경구 항생제는 잇몸 조직의 염증과 플라그를 제어하기 위해 처방됩니다. 경구 항생제는 일반적으로 치주 주머니라고 하는 미생물 감염으로 인해 잇몸과 치아 사이에 형성된 틈새에 넣습니다.

예측 기간 동안 글로벌 치주 치료제 시장 성장을 주도할 더 나은 구강 위생 에 대한 수요 증가 . 구강 위생은 건강을 유지하는 데 가장 중요한 매개변수 중 하나가 되었습니다. 따라서 구강 위생에 대한 인식 증가가 치주 치료제 시장을 주도하고 있으며, 특히 선진국에서 그렇습니다. 세계보건기구(WHO)는 5억 3천만 명이 넘는 어린이가 유치 충치로 고통받고 있다고 밝혔습니다. 더 나은 구강 위생에 대한 인식 증가로 인해 글로벌 치주 치료제 시장은 예측 기간 동안 빠른 속도로 확대될 것입니다. 또한 치주 질환 치료의 기술적 발전으로 2023년에서 2030년까지의 예측 기간 동안 치주 질환 치료 시장 참여자에게 수익성 있는 기회가 확대됩니다.

Data Bridge Market Research는 2022년에 7억 3,480만 달러였던 치주 질환 치료 시장이 2030년까지 6,145,930만 달러로 급증할 것으로 분석했으며, 예측 기간 동안 9.2%의 CAGR을 경험할 것으로 예상합니다. 이는 시장 가치를 나타냅니다. "병원"은 병원에서 발견되는 광범위한 적용 범위로 인해 치주 질환 치료 시장의 유형 세그먼트를 지배합니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

치주 질환 치료 시장 범위 및 세분화

시장 정의

치주 질환은 잇몸과 그 아래 턱뼈의 지지 조직과 주변 조직에 영향을 미치는 진행성 만성 염증성 질환으로 정의됩니다. 이 질환은 치료하지 않으면 잇몸 출혈, 궤양, 치아 상실 및 고통스러운 씹기 문제와 같은 심각한 문제를 초래할 수 있습니다. 잇몸 질환 또는 치주염이라고도 합니다.

글로벌 치주질환 치료 시장 동향

운전자

• 치과 질환의 유병률 증가

세계보건기구(WHO)의 추산에 따르면, 치아 상실을 초래하는 심각한 치주 질환은 중년 성인(35~44세)의 15~20%에서 발견됩니다. 또한, 고령화 인구는 치아 질환(예: 충치 및 치주 질환)의 위험도 초래하여 치아를 완전히 상실하게 됩니다. 예를 들어, WHO에 따르면 65~74세 인구의 약 30%는 천연 치아가 없습니다.

• 노령 인구의 증가

Expanding geriatric population worldwide is predicted to favour the periodontal disease treatment demand as this population is more prone to develop diseases. The number of persons above 65 years is projected to double in the coming years. The old age people are prone to various chronic diseases such as dental disorders, which can foster the demand for the periodontal disease treatment across the globe.

According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.

The increasing geriatric population, higher volume for digital imaging and overpowering medical needs demands for the rise in periodontal disease treatment market growth. Affordability for advanced computers with PERIODONTAL DISEASE TREATMENT aided units have seen a rise over the past few years. Manufacturers of PERIODONTAL DISEASE TREATMENT equipment helps in enhancing the imaging application, the availability of small sized scanners and scanning the patients in the upright position by flat panel detector.

• Rise in inclination towards Periodontal disease treatment

Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies. Recently, higher emphasis has been placed on the dental expertise, which will further act as driver that will lead to the growth of the periodontal disease treatment market in the above mentioned projected timeframe.

Moreover, rise in inclination towards periodontal disease treatment because of the various benefits offered by it such as lower radiation dose to patients in most cases, reasonable alternative to CT in terms of cost and improved resolution, smaller acquisition times for the resolution needed in dentistry and detailed results accelerate the periodontal disease treatment market growth.

Opportunities

• Rising innovations in dentistry

Furthermore, rising innovations in dentistry are pointing towards the linkage between oral disease and medical conditions such as diabetes, heart disease, rheumatoid arthritis, and certain types of cancer. Dental and medical professionals are increasingly collaborating in order to provide optimal care, especially in the cases of medically compromised patients owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, it is observed that emerging technologies are increasingly adopted throughout dentistry. By embracing these improvements, the dental industry is increasingly becoming more patient-centric and fostering greater patient trust. Furthermore, growing convenience and consistency. This will further expand the market's growth rate in the future.

Restraints/Challenges

On the other hand, high cost associated with treatment and diagnostic methods and unfavorable reimbursement scenario are the factors expected to obstruct the periodontal disease treatment market growth. Moreover, limited operating revenue opportunities for research and development of targeted therapies by various pharmaceutical industries is projected to challenge the periodontal disease treatment market in the forecast period mentioned above.

This periodontal disease treatment market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the periodontal disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.

Periodontal Disease Treatment Market Scope

The periodontal disease treatment market is segmented on the basis of type, treatment type, drugs, route of administration, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Gingivitis
• Chronic Periodontal Disease
• Aggressive Periodontal Disease
• Others

Treatment Type

• Non-Surgical Treatment
• Scaling And Root Planning
• Medication
• Surgical Treatment
• Flap Surgery
• Bone Grafts
• Others

Drugs

• Systematic antibiotics
• Doxycycline
• Metronidazole
• Others
• Local antibiotics
• Minocycline hydrochloride
• Chlorhexidine

Route of Administration

• Oral
• Injectable

End-User

• Hospitals
• Clinic
• Dental Clinic
• Dental Academics and Research Institutes
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

Periodontal Disease Treatment Market Regional Analysis/Insights

The periodontal disease treatment market is analysed and market size insights and trends are provided by country, basis of type, treatment type, drugs, route of administration, end-user, and distribution channel as referenced above.

The countries covered in the periodontal disease treatment market  report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.   

North America is expected to dominate the Periodontal disease treatment market due to the presence of major key players, growing initiatives by the local government for the improvement of oral care and provision of knowledgeable dental workforce to address the high unmet needs in this region.

Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to increasing geriatric population and growing awareness amongst consumers about the dental health.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Periodontal disease treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Periodontal disease treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Periodontal disease treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Periodontal Disease Treatment Market Share Analysis

치주 질환 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

치주 질환 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Bausch Health Companies Inc. (캐나다)
• 콜게이트-팔몰리브 컴퍼니(인도) 리미티드
• 마일런 NV(미국)
• 라인 연구소(미국)
• WOCKHARDT(인도)
• Xttrium Laboratories(미국)
• Sunstar Suisse SA (스위스)
• 3M(미국)
• Dexcel Pharma(이스라엘)
• 이준제약(미국)
• 톨마제약(미국)
• 파이저 주식회사(미국)
• Noveome Biotherapeutics, Inc (미국)
• 가켄제약 주식회사(일본)

SKU-47802